Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1757-2215
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status ; volume:12 ; number:1 ; day:28 ; month:1 ; year:2019 ; pages:1-8 ; date:12.2019
Journal of ovarian research ; 12, Heft 1 (28.1.2019), 1-8, 12.2019

Creator
Gadducci, Angiolo
Guarneri, Valentina
Peccatori, Fedro Alessandro
Ronzino, Graziana
Scandurra, Giuseppa
Zamagni, Claudio
Zola, Paolo
Salutari, Vanda
Contributor
SpringerLink (Online service)

DOI
10.1186/s13048-019-0484-6
URN
urn:nbn:de:101:1-2019030315113248108402
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Gadducci, Angiolo
  • Guarneri, Valentina
  • Peccatori, Fedro Alessandro
  • Ronzino, Graziana
  • Scandurra, Giuseppa
  • Zamagni, Claudio
  • Zola, Paolo
  • Salutari, Vanda
  • SpringerLink (Online service)

Other Objects (12)

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer

The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma

The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma

Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers

Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma

The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial

The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial

High-grade serous ovarian cancer: the clone wars

High-grade serous ovarian cancer: the clone wars

High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis

High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis

Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients

Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients

First-Line Management of Advanced High-Grade Serous Ovarian Cancer

First-Line Management of Advanced High-Grade Serous Ovarian Cancer

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer

Principles of dormancy evident in high-grade serous ovarian cancer

Principles of dormancy evident in high-grade serous ovarian cancer

Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer

Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer

Related objects